X-ZELL ranked among Top 50 health tech start-ups in Asia

Singapore, October 2019 – X-ZELL has been ranked amongst the 50 leading health tech start-ups in Asia for the second year running.

Every year, the prestigious list is compiled by Singapore-based analytics and advisory firm, Galen Growth Asia, which has developed a cutting-edge AI platform to map the industry and compare businesses in real time.

“We are truly humbled for being selected again,” commented X-ZELL Founder & CEO, Dr Sebastian C.P. Bhakdi – commending Galen Growth Asia on the “exceptional work” the company does for the local health tech community.

“Next to Galen Growth Asia, I have to extend a huge thank you to the entire team at X-ZELL for making it two in a row. So much has happened since we were first recognised as one of Asia’s most innovative health tech start-ups in the fall of 2018 – from our first clinical publication all the way through to moving our HQ and leadership team from Bangkok to Singapore.

“Thank you also to our investors and partners for your ongoing support and believing in our vision of zero deaths due to undetected cancer – it would not have been possible without you.”

To celebrate the milestone, X-ZELL will be featured at the 2019 Galen Growth Asia HealthTech Summit in Singapore next month.

For more information on the event, visit www.galengrowth.asia/events/healthtech-summit-2019.


Media Contact:

Sebastian Grote
Head of Strategy, Marketing & Communications
+65 9630 0706


Next-generation cytology

© 2023 X-ZELL INC

Find Us